glp-1 dangers Is the Same as Ozempic? Understanding Key Differences A recent post hoc analysis

doi: 10.1111/ejn.70156 5

The disproportionate analyses conducted concurrently with our study, based on the FAERS database with varying year spans, also indicate no direct association between GLP-1RAs and SSIBs [55, 56]

[PMID: 10092755] PubMed record related to this compound for laboratory literature review

Much of the current evidence is preclinical (cell and animal studies), and human data is still limited

10.1172/jci.insight.93382 Summary Keywords glucagon-like peptide-1 receptor agonists, ocular diseases, glaucoma, diabetic retinopathy, mechanism Citation Xie Z, Yang Z, Tian D and Chen Y (2025) Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact

(September 07, 2024)